McKesson Corporation vs Banco Santander SA — how do they compare? McKesson Corporation trades at $899.6 (market cap $105.14B), while Banco Santander SA trades at $14.88 (market cap $211.63B). The key difference: Banco Santander SA is far larger — about 2× McKesson Corporation's market cap, and Banco Santander SA pays the higher dividend (1.89%). Which is the better fit depends on your goals.
| MCK | SAN | |
|---|---|---|
Market Cap | $105.14B | $211.63B |
Sector | Health | Financials |
52-Week High | $995.69 | $14.71 |
52-Week Low | $659.01 | $9.37 |
Enterprise Value | $111.67B | — |
Dividend Yield | 0.42% | 1.89% |
Trailing returns across standard periods
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →Santander's focus is on retail and commercial banking. Latin America is geographically the largest operation, with Brazil by far the largest. Its continental European business is still mainly Iberian. Santander's U.K. presence is the result of the acquisition of building society Abbey. In the U.S., Santander operates a vehicle finance business and a regional bank focused on the Northeastern states.
Read more on SAN →